Michael LeBlanc is Director of Pharmacy Professional Practice for Horizon Health Network, New Brunswick. He is responsible for the development, evaluation and monitoring of clinical pharmacy services. He graduated from Memorial University of Newfoundland in 1998 and received his PharmD from Idaho State University in 2009.
Michael has been an oncology pharmacist for 25 years with a focus on the prevention and management of cancer-treatment associated toxicities. He is active in practice-based research and providing support for patients receiving oral anticancer medications.
Michael is a member of the CAPHO Research Committee, FCAPHO Task Force, ambulatory oncology cpKPI working group, and the CAPHO24 Planning Committee. He is also active in the Canadian Society of Hospital Pharmacists where he gained fellowship status in 2015 and is the current chair of the Board of Trustees for the CSHP Research and Education Foundation.